Sickle cell vaso-occlusive pain crisis in adults: alternative strategies for management in the emergency department.
Journal Article (Journal Article)
The gene for sickle cell disease is carried by 8% of the African-American population in the United States. The primary care physician is often called upon to recognize and treat one of the major sequelae of sickle cell disease--vaso-occlusive pain crisis. An injectable nonsteroidal anti-inflammatory drug has recently become available and may offer some improvement in outcome of vaso-occlusive pain crises. We present five case reports reviewing various current therapeutic options, including newer pharmacologic agents, and comment on alternatives to impatient management of pain crises. The use of the emergency department short-term observation unit as an alternative to hospitalization is discussed.
Full Text
Duke Authors
Cited Authors
- Sanders, DY; Severance, HW; Pollack, CV
Published Date
- August 1992
Published In
Volume / Issue
- 85 / 8
Start / End Page
- 808 - 811
PubMed ID
- 1302470
International Standard Serial Number (ISSN)
- 0038-4348
Digital Object Identifier (DOI)
- 10.1097/00007611-199208000-00005
Language
- eng
Conference Location
- United States